global prevalence
Recently Published Documents


TOTAL DOCUMENTS

476
(FIVE YEARS 271)

H-INDEX

66
(FIVE YEARS 15)

2022 ◽  
Vol 15 (1) ◽  
Author(s):  
Aida Vafae Eslahi ◽  
Sima Hashemipour ◽  
Meysam Olfatifar ◽  
Elham Houshmand ◽  
Elham Hajialilo ◽  
...  

Abstract Background Strongyloides stercoralis, a soil-transmitted helminth, occurs in humans, non-human primates, dogs, cats and wild canids. The zoonotic potential between these hosts is not well understood with data available on prevalence primarily focused on humans. To increase knowledge on prevalence, this review and meta-analysis was performed to estimate the global status of S. stercoralis infections in dogs. Methods Following the PRISMA guidelines, online literature published prior to November 2020 was obtained from multiple databases (Science Direct, Web of Science, PubMed, Scopus and Google Scholar). Prevalence was calculated on a global and country level, by country income and climate, and in stray/animal shelter dogs versus owned dogs. Statistical analyses were conducted using R-software (version 3.6.1). Results From 9428 articles, 61 met the inclusion criteria. The estimated pooled global prevalence of S. stercoralis in dogs was 6% (95% CI 3–9%). Infection was found to be the most prevalent in low-income countries with pooled prevalence of 22% (95% CI 10–36%). The highest pooled prevalence of S. stercoralis in dogs was related to regions with average temperature of 10–20 °C (6%; 95% CI 3–11%), an annual rainfall of 1001–1500 mm (9%; 95% CI 4–15%) and humidity of 40–75% (8%; 95% CI 4–13%). Prevalence was higher in stray and shelter dogs (11%; 95% CI 1–26%) than in owned dogs (3%; 95% CI 1–7%). Conclusions As with S. stercoralis in humans, higher prevalence in dogs is found in subtropical and tropical regions and lower-income countries, locations which also can have high dog populations. While this study presents the first estimated global prevalence of S. stercoralis in dogs, it is potentially an underestimation with 15 of 61 studies relying on diagnostic methods of lower sensitivity and a paucity of data from most locations. Standardized protocols (e.g. quantity of feces and number of samples for a Baermann) in future studies could improve reliability of results. More prevalence studies and raising veterinary awareness of S. stercoralis are needed for a One Health approach to protect humans and dogs from the impact of the infection. Graphical Abstract


2022 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Taiwo H. Odugbemi ◽  
Ademola A. Abdulbasit ◽  
Oluwafemi Atolagbe ◽  
Feyisayo Oyolola ◽  
Wasiu Adekunle ◽  
...  

Author(s):  
Nader Salari ◽  
Mohsen Kazeminia ◽  
Niloufar Hemati ◽  
Mojtaba Ammari-Allahyari ◽  
Masoud Mohammadi ◽  
...  

2021 ◽  
pp. 1-20
Author(s):  
Sonja Y. Hess ◽  
Alexander C. McLain ◽  
Haley Lescinsky ◽  
Kenneth H. Brown ◽  
Ashkan Afshin ◽  
...  

Abstract Background: The Global Burden of Disease (GBD) Study provides estimates of death and disability from 87 risk factors, including some micronutrient deficiencies. Objectives: To review methodological changes that led to large differences in the disease burden estimates for vitamin A and zinc deficiencies between the GBD 2017 and 2019 Studies. Methods: GBD publications were reviewed; additional information was provided by GBD researchers. Results: Vitamin A deficiency prevalence is based on plasma retinol concentration, whereas the estimate for zinc deficiency prevalence uses dietary adequacy as a proxy. The estimated global prevalence of vitamin A deficiency for children aged 1-4 years in the year 2017 decreased from 0.20 (95%CI 0.17-0.24) in GBD 2017 to 0.16 (95%CI 0.15-0.19) in GBD 2019, while the global prevalence of zinc deficiency did not change between the two studies (0.09 (95%CI 0.04-0.17) and 0.09 (95%CI 0.03-0.18)). New to 2019 was that meta-analyses were performed using Meta Regression – Bayesian, Regularized, Trimmed (MR-BRT), a method developed for GBD. Due to this and multiple other methodological changes the estimated number of deaths due to vitamin A deficiency dropped from 233,000 (179,000–294,000) to 24,000 (3,000–50,000) from GBD 2017 to 2019, and for zinc deficiency from 29,000 (1,000–77,000) to 2,800 (700–6,500), respectively. Conclusion: The changes in the estimated disease burdens due to vitamin A and zinc deficiencies in the GBD reports from 2017 to 2019 are due primarily to changes in the analytical methods employed, so may not represent true changes in disease burden. Additional effort is needed to validate these results.


2021 ◽  
pp. 1-9
Author(s):  
Xin Shen ◽  
Hao Dong ◽  
Heng Jiang ◽  
Hui Cao ◽  
Rowan Dowling ◽  
...  

Author(s):  
Nader Salari ◽  
Niloofar Darvishi ◽  
Shamarina Shohaimi ◽  
Yalda Bartina ◽  
Melika Ahmadipanah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document